FindTrial
Sign In

Prognostic value of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography after allogeneic hematopoietic stem cell transplantation in lymphoblastic lymphoma

Prognostic value of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography after allogeneic hematopoietic stem cell transplantation in lymphoblastic lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046709
Enrollment
Unknown
Registered
2021-05-27
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoma

Interventions

case series:none

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. LBL patients diagnosed between April 2010 and December 2019; 2. Perform allogeneic stem cell transplantation in our hospital; 3. Perform 18F-FDG PET-CT examination after transplantation in our hospital, and the examination time is 0-12 months after transplantation; 4. Follow-up time> 6 months or death due to lymphoma-related causes during the follow-up period.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Progression-free survival;Overall survival;—

Countries

China

Contacts

Public ContactDai Na

The First Affiliated Hospital of Soochow University

dnsundaysong@163.com+86 13771793585

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 16, 2026